Through multivariate Cox regression analysis and OS-KM survival curves, we found that patients with ACC, LGG, and PAAD had poor prognosis when PTBP3 was highly expressed, but patients with KIRC had better prognosis. Here, PTBP3 is linked to pancreatic adenocarcinoma.